AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Episode 76
Biotech Hangout
Merck Keynote 671 Study and Overall Survival in Lung Cancer
Discussion on the Merck Keynote 671 study, focusing on resectable lung cancer at stage 2, 3A, or 3B. The study reveals that giving Keytruda before surgical resection has shown an overall survival advantage, marking a significant development in neo-adjuvant studies with a PD-1 in lung cancer.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode